Contributions of the molecular biologist in gastrointestinal cancer and precancer screening: current possibilities and future prospects

Gastrointest Endosc Clin N Am. 1997 Jan;7(1):147-64.

Abstract

Molecular biology has become an integral part of research aimed at improving diagnosis, therapy, and ultimately prevention of malignant disease. This article focuses on the current possibilities and limitations of molecular biology to improve existing screening and surveillance protocols in specific gastrointestinal disease entities frequently encountered in routine clinical practice.

Publication types

  • Review

MeSH terms

  • Adenomatous Polyposis Coli / genetics
  • Adenomatous Polyposis Coli / prevention & control
  • Barrett Esophagus / genetics
  • Barrett Esophagus / prevention & control
  • Carcinoma / genetics
  • Carcinoma / prevention & control
  • Colitis, Ulcerative / complications
  • Colitis, Ulcerative / genetics
  • Colitis, Ulcerative / prevention & control
  • Colonic Neoplasms / genetics
  • Colonic Neoplasms / prevention & control
  • Colorectal Neoplasms, Hereditary Nonpolyposis / genetics
  • Colorectal Neoplasms, Hereditary Nonpolyposis / prevention & control
  • Gastrointestinal Neoplasms / diagnosis
  • Gastrointestinal Neoplasms / genetics*
  • Gastrointestinal Neoplasms / prevention & control*
  • Humans
  • Mass Screening*
  • Pancreatic Neoplasms / genetics
  • Pancreatic Neoplasms / prevention & control
  • Population Surveillance*
  • Precancerous Conditions / genetics*